CLINICAL_TRIALS
trial_result
· 2023-03-01
Clinical Trial Update: A Clinical Trial to Assess Subjects With Dry Eye Disease. [Phase 2]
Summary
A Phase 2 clinical trial evaluating reproxalap for dry eye disease has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2023-03-01